Incidental findings
The Cost of Chasing — an Incidental Finding
An incidental finding is something your scan discovered that nobody was looking for. Investigating it is often necessary — but the tests, waiting, and expense that follow are rarely explained before the original scan is ordered.
Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed September 2026
- Not always urgent — Many incidental findings can be watched over time rather than acted on immediately. The urgency depends on the specific finding.
- The cascade is real — One unexpected finding can trigger a chain of scans, biopsies, and specialist reviews that were never part of your original plan.
- Costs are rarely disclosed upfront — The financial impact of follow-up investigations is almost never explained before a whole-body scan is ordered.
- Your team decides the path — Whether to investigate, how quickly, and by what method depends on your age, overall health, and the nature of the finding.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
An incidental finding means your scan found something unexpected. Investigating it usually means more imaging, sometimes a biopsy, and occasionally specialist reviews — each adding cost and time. Whether it is worth pursuing depends on your age, your overall health, and the nature of the finding. Your treating team decides the next step, not you alone.
A whole-body PET-CT at CION costs from Rs 10,499 — among the lowest published prices in Hyderabad. Indicative price, as of September 2026.
What tests are usually needed after an incidental finding?
Most incidental findings require at least one more scan before any action is taken. A contrast CT, an MRI, or a dedicated ultrasound is usually the first step — used to examine the finding's shape, density, and response to contrast dye.
If imaging alone cannot settle the question, tissue is needed. A biopsy — needle-guided, endoscopic, or surgical — tells a pathologist exactly what the cells are, and adds significant cost depending on the site.
Some findings go to a tumour board or a second specialist before any test is ordered. That adds waiting rather than direct cost — but the time carries weight when treatment for your primary diagnosis is waiting too.
What should you ask before agreeing to further tests?
- What exactly did the scan show, and where in the body is it?
- What does the radiologist think it most likely is?
- What is the risk of watching it for three months rather than testing now?
- What is the full sequence of tests being proposed?
- What does each step cost, and what can safely be deferred?
- Is there a simpler or less expensive test that answers the same question?
How does the investigation path differ by finding type?
| Finding type | Typical first follow-up | May also require | Cost direction |
|---|---|---|---|
| Pulmonary nodule (lung spot) | Low-dose CT chest in 3–12 months | PET-CT or bronchoscopy if size increases | Moderate; rises sharply if biopsy is needed |
| Adrenal incidentaloma | Hormonal blood and urine tests | CT washout study or MRI adrenal | Moderate; blood tests keep entry cost lower |
| Liver lesion | Contrast MRI liver | Biopsy if MRI is not conclusive | High if biopsy is required |
| Thyroid nodule | Ultrasound thyroid | Fine-needle aspiration biopsy | Low to moderate; ultrasound is widely available |
PET-CT Partner Centres
PET-CT Scan Centres in Hyderabad
CION offers PET-CT scans through 4 trusted partner PET-CT centres across Hyderabad, so you can choose the one closest to you. Call 18002028726 and we’ll guide you to the earliest available appointment.
PET-CT Centre — Punjagutta
PET-CT Centre — Himayatnagar
PET-CT Centre — Narayanaguda
These are partner diagnostic centres within the CION network. Toll-free booking: 18002028726.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a straight answer from a specialist
45 minutes, your reports reviewed, your questions answered in plain language.
What do the terms in your scan report actually mean?
- Incidentaloma
- A finding discovered by accident on a scan done for a different reason. The name does not mean cancer; most incidentalomas are benign.
- Surveillance
- Watching a finding with repeat scans at defined intervals rather than acting immediately. Used when the finding is small and the short-term risk is low.
- Radiological characterisation
- Using imaging features — shape, density, contrast behaviour — to judge whether a finding looks benign or concerning, without taking tissue.
- Tissue biopsy
- Removing a small sample of cells so a pathologist can examine them under a microscope. The only definitive way to identify what a finding actually is.
- False positive
- A finding that looks suspicious on a scan but is confirmed to be benign after further investigation. Common in whole-body screening contexts.
Did you know?
Incidental findings unrelated to the original reason for scanning are reported in a significant proportion of patients who undergo whole-body PET-CT. Most turn out to be benign — but establishing that almost always requires at least one further investigation.
The downstream costs and the waiting involved are rarely discussed before the original scan is ordered.
Source: European Society of Radiology — guidance on incidental findings in oncological imaging
Is it always worth pursuing an incidental finding?
When is it reasonable not to investigate immediately?
When the finding is small, its imaging features are reassuring, and the patient is elderly, frail, or already managing a demanding treatment, surveillance — repeat imaging at a defined interval — is often the right answer. The question your oncologist asks is whether the result of investigation would change what happens next. If the answer is no, immediate action may not add value. Ask that question directly at your next appointment.
What if we cannot afford the follow-up tests?
Raise it before tests are booked, not after. Some investigation sequences have lower-cost alternatives that answer roughly the same question. For findings where immediate action is not clinically required, a defined surveillance window reduces upfront expenditure. Your oncologist cannot offer these options without knowing cost is a constraint, so the conversation is worth having early rather than quietly declining tests later.
Can we get a second opinion on the scan images before agreeing to more tests?
Yes, and it is a legitimate step. Radiologists occasionally disagree on how to characterise a finding, and a second reading from a specialist in that body region — a chest radiologist for a lung finding, a hepatobiliary radiologist for a liver lesion — can sometimes avoid a biopsy by providing a more confident non-invasive answer. Ask your oncologist to arrange this before any invasive investigation is scheduled.
Book a PET-CT at CION from Rs 10,499 — among the lowest published prices in Hyderabad — with an oncologist-reviewed report and a free Rs 950 consultation, across 4 partner centres. Indicative price, as of September 2026.
Explore 94 more Understanding Your PET-CT Report topics
Incidental Findings
- A Second Unrelated Cancer Found on PET-CT
- An Incidental Bone Finding on PET-CT
- An Incidental Breast Finding on PET-CT
- An Incidental Kidney or Adrenal Finding
- An Incidental Liver Lesion on PET-CT
- An Incidental Lung Nodule Found on PET-CT
- An Incidental Prostate Finding on PET-CT
- An Incidental Thyroid Nodule on Your PET Scan
- Do All Incidental Findings Need Investigation?
- Focal Bowel Uptake: Could It Be a Polyp?
- Incidental Findings on a PET-CT Scan: What They Are
- Incidental Heart Findings on a Cancer PET Scan
- The Cost of Chasing an Incidental Finding
- What to Ask Your Doctor About an Incidental Finding
False Positives, False Negatives & Pitfalls
- Bladder, Kidney and Ureter Activity on PET
- Bone Marrow Uptake After Growth Factor Injections
- Bowel Uptake: Normal, Inflammation or Something Else?
- Brown Fat Uptake: A Common Cause of Confusing Findings
- Does a Suspicious PET Finding Always Need a Biopsy?
- Getting a Second Read of Your PET-CT Images
- How Often Is a PET-CT Scan Wrong?
- Muscle Uptake After Exercise or Injections
- Thymic and Rebound Uptake in Younger Patients
- Uptake After Radiotherapy: Inflammation or Disease?
- Uptake at a Biopsy or Surgery Site
- What Causes a False Negative on a PET Scan?
- What Causes a False Positive on a PET Scan?
- What Happens If Two Scans Disagree?
- Which Cancers Do Not Show Well on PET-CT?
- Why the Brain Always Lights Up on PET
Infection, TB & Inflammation on PET
- Can Tuberculosis Look Like Cancer on a PET Scan?
- Dental Infection and Jaw Uptake on PET
- Fungal Infection and Abscess on PET-CT
- How Long Should You Wait After an Infection Before a PET Scan?
- If It Might Be Infection, What Test Comes Next?
- Inflammation After Injections, Vaccines and Cannulas
- Old Healed TB and Calcified Nodes on PET-CT
- PET-CT for Fever of Unknown Origin
- PET-CT for Suspected Infection in Implants and Prostheses
- PET-CT for Vasculitis and Inflammatory Conditions
- Pneumonia and Recent Chest Infection on PET
- Sarcoidosis on PET-CT: The Great Mimic
- TB or Cancer? How Doctors Tell Them Apart
- Thyroid Uptake on PET: Diffuse vs Focal
Reading Your Report: Core Terms
- 'Cannot Be Excluded' and Other Cautious Phrases
- 'Deauville Score' on a Lymphoma PET Report
- 'FDG Avid': What It Means on Your Report
- 'Hypermetabolic': What the Word Actually Means
- 'Hypometabolic' and 'Photopenic' Findings
- 'Impression' vs 'Findings': Which Section Should You Read?
- 'Interval Change' and 'Stable Since Previous Study'
- 'Krenning Score' on a DOTANOC or DOTATATE Report
- 'Lymphadenopathy' on Your PET Report
- 'Metabolically Active Disease': What It Tells You
- 'Metastasis' and 'Distant Spread' on Your Report
- 'Mildly FDG Avid' vs 'Intensely FDG Avid'
- 'No Abnormal FDG Uptake': Is That a Clear Scan?
- 'Physiological Uptake': Normal Areas That Always Light Up
- 'Residual Disease' vs 'Complete Metabolic Response'
- 'Sub-Centimetre Node' and Why Size Matters on PET
- 'Suspicious for Malignancy': How Certain Is That?
- How Long Does a PET-CT Report Take?
- How to Read Your PET-CT Report: A Section-by-Section Guide
- Should You Read Your Own PET-CT Report Before the Consult?
- TNM Staging on a PET-CT Report
- Why Your Report Mentions the Liver and Blood Pool
Response Assessment Scores & Criteria
- Complete Metabolic Response: What It Means
- Deauville Score 1 to 5: The Lymphoma Scale Explained
- End-of-Treatment PET Scan: What It Decides
- How Doctors Judge Whether Treatment Is Working on PET-CT
- Interim PET Scan During Chemotherapy: Why It Is Done
- Metabolic Response vs Size Response: Why They Differ
- PERCIST Criteria: How Metabolic Response Is Measured
- Partial Metabolic Response: Is That Good Enough?
- Progressive Metabolic Disease: What Happens Next
- RECIST vs PERCIST: Size vs Activity
- Stable Metabolic Disease: Good News or Bad?
- Tumour Flare and Pseudoprogression on PET
- What Is a Deauville 3 and Why Is It Ambiguous?
- Why the Scan Says One Thing and You Feel Another
SUV Values Explained
- Comparing SUV Between Two Scans: Is It Meaningful?
- Does a Higher SUV Mean a More Aggressive Cancer?
- Factors That Change Your SUV Reading
- High SUV but Not Cancer: When the Number Misleads
- Is My SUVmax of 4 High? Reading Your Specific Number
- Low SUV but Still Cancer: The PET-Negative Cancers
- SUV in Non-Cancer Conditions
- SUVmax, SUVmean and SUVpeak: What Is the Difference?
- What Is SUV on a PET Scan?
- What Is a Normal SUV Value?
- What SUV Value Indicates Cancer?
- Why Blood Sugar Changes Your SUV Result
- Why Did My SUV Go Down but Not to Zero?
- Why Did My SUV Go Up After Treatment?
Your next step
Talk to an oncologist about your scan
Your PET-CT report read by a senior oncologist, explained in plain language, with a free 45-minute consultation.
Common questions
Frequently asked questions
How much does investigating an incidental finding typically cost?
It depends entirely on the finding, its location, and the investigation sequence your team recommends. A follow-up ultrasound costs far less than a liver biopsy with a hospital stay, and costs compound quickly when one test leads to another. Before agreeing to the full sequence, ask your oncologist to map out each step and its approximate cost so you are not surprised partway through. Any figure you are quoted is indicative and varies between centres.
Is an incidental finding always serious?
Most incidental findings, when fully investigated, turn out to be benign — cysts, benign nodules, normal anatomical variants, and old healed infections are among the most common explanations. That said, 'most' is a population figure, not reassurance for any individual reader. Whether your specific finding is serious is a question only further investigation and your oncologist's assessment can answer. Do not read your own result against a general statistic.
Can we just watch and wait instead of investigating immediately?
For many types of incidental finding, yes. Surveillance — monitoring with repeat imaging at defined intervals — is the standard approach for several small findings, including many pulmonary nodules and small adrenal incidentalomas. Whether it applies to your finding depends on its size, location, and imaging features. Ask your oncologist whether surveillance is appropriate and what change would prompt earlier action.
What if the incidental finding is in a completely different part of the body from my cancer?
This is one of the most unsettling situations after a whole-body scan. The finding may be unrelated to your cancer, or it may represent disease in an unexpected site — and imaging alone often cannot tell these apart. An unexpected finding in a different region does not automatically mean your cancer has spread, but investigation is usually needed before treatment planning can proceed with confidence. Your oncologist and tumour board will interpret it in the context of your full picture.
Will investigating the incidental finding delay my main cancer treatment?
It can. If the finding changes the diagnosis — for example, if it represents disease in a site that was thought to be clear — the treatment plan changes with it. If it turns out to be unrelated, treatment proceeds. Investigation is usually measured in weeks, not months. In urgent situations your oncologist may begin treatment and investigate the finding in parallel. Ask about the timing directly rather than assuming either outcome.
Should I tell my oncologist if cost is a concern?
Yes, and before tests are booked. Oncologists in India routinely factor cost into investigation planning. Some follow-up sequences have lower-cost alternatives; some steps can be deferred when the clinical risk is acceptable. Declining tests silently after they are already scheduled creates more uncertainty than raising the concern early. The conversation is expected, not exceptional.